188 related articles for article (PubMed ID: 33617370)
21. Rotenone restrains the proliferation, motility and epithelial-mesenchymal transition of colon cancer cells and the tumourigenesis in nude mice via PI3K/AKT pathway.
Xue W; Men S; Liu R
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1484-1494. PubMed ID: 32282954
[TBL] [Abstract][Full Text] [Related]
22. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells.
Peairs A; Dai R; Gan L; Shimp S; Rylander MN; Li L; Reilly CM
Cell Mol Immunol; 2010 Mar; 7(2):123-32. PubMed ID: 20140007
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.
Albrecht DS; Clubbs EA; Ferruzzi M; Bomser JA
Chem Biol Interact; 2008 Jan; 171(1):89-95. PubMed ID: 17931610
[TBL] [Abstract][Full Text] [Related]
24. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis.
Liu D; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang L; Wei W
Eur J Pharmacol; 2012 Sep; 690(1-3):214-25. PubMed ID: 22760071
[TBL] [Abstract][Full Text] [Related]
25. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
Zhou H; Fu LX; Li L; Chen YY; Zhu HQ; Zhou JL; Lv MX; Gan RZ; Zhang XX; Liang G
J Ethnopharmacol; 2020 Oct; 261():113118. PubMed ID: 32621953
[TBL] [Abstract][Full Text] [Related]
26. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
Farabegoli F; Govoni M; Spisni E; Papi A
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
[TBL] [Abstract][Full Text] [Related]
27. Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
Chen NG; Lu CC; Lin YH; Shen WC; Lai CH; Ho YJ; Chung JG; Lin TH; Lin YC; Yang JS
Oncol Rep; 2011 Oct; 26(4):939-47. PubMed ID: 21743966
[TBL] [Abstract][Full Text] [Related]
28. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
29. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
[TBL] [Abstract][Full Text] [Related]
30. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway.
Park G; Yoon BS; Moon JH; Kim B; Jun EK; Oh S; Kim H; Song HJ; Noh JY; Oh C; You S
J Invest Dermatol; 2008 Oct; 128(10):2429-41. PubMed ID: 18463684
[TBL] [Abstract][Full Text] [Related]
31. Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation.
Park SB; Bae JW; Kim JM; Lee SG; Han M
Int J Mol Med; 2012 Nov; 30(5):1211-8. PubMed ID: 22923012
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude mice.
Yuan JH; Li YQ; Yang XY
Pharmacology; 2007; 80(4):269-78. PubMed ID: 17657175
[TBL] [Abstract][Full Text] [Related]
33. (-)-Epigallocatechin gallate suppresses adipocyte differentiation through the MEK/ERK and PI3K/Akt pathways.
Kim H; Sakamoto K
Cell Biol Int; 2012 Feb; 36(2):147-53. PubMed ID: 21902673
[TBL] [Abstract][Full Text] [Related]
34. PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.
Liu S; Wang XJ; Liu Y; Cui YF
Am J Chin Med; 2013; 41(3):629-42. PubMed ID: 23711146
[TBL] [Abstract][Full Text] [Related]
35. Epigallocatechin-3-gallate inhibits adipogenesis through down-regulation of PPARγ and FAS expression mediated by PI3K-AKT signaling in 3T3-L1 cells.
Wu M; Liu D; Zeng R; Xian T; Lu Y; Zeng G; Sun Z; Huang B; Huang Q
Eur J Pharmacol; 2017 Jan; 795():134-142. PubMed ID: 27940057
[TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase.
Moradzadeh M; Hosseini A; Erfanian S; Rezaei H
Pharmacol Rep; 2017 Oct; 69(5):924-928. PubMed ID: 28646740
[TBL] [Abstract][Full Text] [Related]
37. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.
Wubetu GY; Shimada M; Morine Y; Ikemoto T; Ishikawa D; Iwahashi S; Yamada S; Saito Y; Arakawa Y; Imura S
J Gastroenterol Hepatol; 2016 Jan; 31(1):256-64. PubMed ID: 26241688
[TBL] [Abstract][Full Text] [Related]
38. Isovitexin attenuates tumor growth in human colon cancer cells through the modulation of apoptosis and epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.
Zhu H; Zhao N; Jiang M
Biochem Cell Biol; 2021 Dec; 99(6):741-749. PubMed ID: 34219464
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer.
Man GCW; Wang J; Song Y; Wong JH; Zhao Y; Lau TS; Leung KT; Chan TH; Wang H; Kwong J; Ng TB; Wang CC
BMC Cancer; 2020 Oct; 20(1):964. PubMed ID: 33023525
[TBL] [Abstract][Full Text] [Related]
40. Cooperation between Shh and IGF-I in promoting myogenic proliferation and differentiation via the MAPK/ERK and PI3K/Akt pathways requires Smo activity.
Madhala-Levy D; Williams VC; Hughes SM; Reshef R; Halevy O
J Cell Physiol; 2012 Apr; 227(4):1455-64. PubMed ID: 21618536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
